BPH
Tips for Leading Your Own Case Study
Do not use existing case studies as templates for your presentations.
Be creative in your presentation style and approach.
Always read and understand the full assignment and rubric.
Address all points outlined in the rubric to achieve a good grade.
Avoid adding unnecessary "fluff" to your presentation to stay within time limits.
Engage the class effectively, focusing on leading a discussion rather than delivering a standard presentation.
Become an expert on the disease being presented.
Read extensive scientific literature on your topic (avoid sources like WebMD).
Familiarize yourself with all aspects of the topic, even if certain literature does not seem directly relevant.
Anatomy and Conditions Related to Benign Prostatic Hyperplasia (BPH)
Anatomy Overview
Diagram and key terms not detailed in the transcript include:
Normal Prostate vs. Enlarged Prostate
Structures involved: Bladder, Seminal vesicles, Ejaculatory duct, and Prostatic urethra.
Definitions of Key Terms
Benign: Refers to tumors that remain localized and cells resemble the tissue of origin.
Malignant: Refers to tumors that spread, are invasive, and cells do not resemble the tissue of origin.
Prostatic: Pertaining to the prostate gland.
Function of the Prostate:
Produces fluid that contributes to semen.
Lubricates the urethra.
Protects, nourishes, and aids in the mobility of sperm.
Hyperplasia: Refers to an increase in the number of cells within a tissue or organ.
Understanding BPH
Prevalence and Statistics
BPH is not always pathological and commonly encountered.
Prevalence statistics:
8% of males in their 40s.
50% in males in their 60s.
80% in males in their 90s.
In the US, as of 2000:
BPH accounted for $1.1 billion in direct healthcare expenditures.
By 2013, this increased to $1.9 billion.
Total of 4.4 million office visits annually related to BPH, 117,000 emergency room visits, and 105,000 hospitalizations.
1 in 4 men will experience BPH in their lifetime.
Symptoms of BPH
Understand which terms are appropriate to describe symptoms.
Key questions to consider:
Could symptoms of BPH be life-threatening?
Disease Definition and Understanding BPH
Disease Definition: Per Braun & Anderson (2017), "Disease is the functional impairment of cells, tissues, organs, or organ systems."
Inquiry points:
Are symptoms necessary for the designation of a disease?
Assessing which causes greater obstruction: distortion of urethra or compression.
Case Study Examined: William Murdock
Patient Profile
William Murdock, 76 years old, a Walmart greeter who enjoys coffee and smokes daily.
Chief complaints:
Lack of sleep and irritability.
Frequent urination at night (nocturia).
Difficulty emptying bladder.
Incontinence.
Patient History of Present Illness (HPI)
Relevant issues:
Recurrent urinary tract infections (UTIs)
Hospitalizations due to pyelonephritis.
Current urinary frequency, urgency, nocturia, and occasional incontinence.
Obtain Urinalysis results for further evaluation.
Urinalysis Results
Key Parameters
All parameters within normal limits despite recurrent UTIs.
Notable urinalysis results:
Negative for nitrites (normally indicative of UTIs).
Reference values outlined:
Specific Gravity (SG): 1.016-1.022.
pH: 5.0-6.5.
WBC: 0-5 WBC/high power field.
RBC: 0-5 RBC/high power field.
Assessment of General Health
Patient's Past Medical History (PMH)
Relevant conditions:
Hypothyroidism.
Adenomatous colonic polyps.
Varicocele.
Lipoma.
COPD likely due to smoking.
Anemia, degenerative joint disease (DJD), ip fracture.
Understanding medication use regarding the above conditions.
Physical Exam Findings
General Observations
General health appears stable (NAD - no apparent distress).
Vital signs noted:
Blood pressure slightly elevated.
Respiratory rate (RR) slightly elevated.
BMI indicating obesity.
Specific Findings from Exam
Prostate examination through Digital Rectal Exam (DRE) indicates a large prostate (70g).
Vacuous comments on various systems, e.g., Skin, HEENT, Abdomen, etc.
Evaluating Severity of Lower Urinary Tract Symptoms (LUTS)
International Prostate Symptom Score (IPSS)
Numbered questions allow for categorizing symptom severity:
Mild <7.
Moderate 8-20.
Severe >20.
Urinary Function Tests and Blood Test Evaluations
Key Function Tests
Uroflowmetry and residual urine volume analysis indicate potential obstruction.
Urine flow rate (Qmax): 7 ml/sec (indicating possible obstruction if < 10 ml/sec).
Blood Chemistry and Diagnostic Tests
Discussion of electrolyte balance, renal function, hepatic function, and anemia considerations.
Specific blood parameters noted:
TSH and T4 levels indicating suboptimal hypothyroid treatment.
Elevated fasting glucose and cholesterol levels.
Prostate-Specific Antigen (PSA) Monitoring
PSA Results
PSA levels:
13 months ago: 5.0 ng/ml.
Current: 5.2 ng/ml (normal range for age).
Continuous increase may indicate potential malignancy.
Discussion on Possible Prostate Cancer vs. BPH
Differentiating Between Conditions
Investigate PSA changes and DRE findings for indications of cancer.
Metabolic Syndrome and BPH Implications
Understanding Metabolic Syndrome
Highlights cluster of conditions increasing heart disease, stroke, and diabetes risks.
Chronic inflammation may correlate with BPH symptomatology.
Recommended Treatment Options for BPH
Pharmacological Treatments
Consideration of alpha-blockers and 5α-reductase inhibitors for symptom relief.
Surgical options referenced:
Transurethral Resection of the Prostate (TURP) as the standard intervention.
Notable Surgical Outcomes
Review outcomes and complication rates associated with various treatments provided in a comparative format.
Recent References for Case Study
Braun, C.A., & C.M. Anderson. 2017. Pathophysiology, A Conceptual Approach.
Campos-Pinheiro, L., & Martins-Pisco, J. 2012. Treatment of BPH.
Dirac, A. 2019. Global Burden of BPH Analysis.
Additional citations provided for further study.
Concluding Notes
Importance of continuously seeking recent primary literature for case studies.
Understanding underlying pathophysiology is critical for appropriate diagnosis and treatment planning.